Lv1
48 积分 2024-11-01 加入
Discovery and Characterization of RP03707: A Highly Potent and Selective KRASG12D PROTAC
3天前
已完结
Real-World outcomes of Non-Small cell lung cancer patients harbouring KRAS G12C and KRAS G12D mutations
1个月前
已完结
Novel Macrocyclic NLRP3 Inhibitors
5个月前
已完结
Pharmacologic restoration of GTP hydrolysis by mutant RAS
6个月前
已完结
皖公网安备34019202002308
